← Back to Search

Dietary Supplement

Health and Wellness Products for Pain

N/A
Waitlist Available
Led By Emily K. Pauli, PharmD
Research Sponsored by Radicle Science
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Expresses a willingness to take a study product and not know the product identity (active or placebo) until the end of the study
Be older than 18 years old
Must not have
Reports a diagnosis of heart disease when a known contraindication exists for any of the active ingredients studied: NYHA (New York Heart Association) Class III or IV congestive heart failure, Atrial fibrillation, Uncontrolled arrhythmias
Reports a diagnosis of liver or kidney disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks

Summary

This trial tested products to see if they could help reduce pain and improve overall health.

Who is the study for?
Adults over 21 in the US who want to reduce pain with health and wellness products can join. They must be willing to take an unknown product (active or placebo) until study's end, not be pregnant/breastfeeding, have no severe heart/liver/kidney disease, not on conflicting meds like anticoagulants/high-dose steroids/MAOIs, and not heavy drinkers.
What is being tested?
The trial is testing different health and wellness products against placebos to see if they help with various types of pain. Participants are randomly assigned a real product or a fake one without knowing which they received until the study concludes.
What are the potential side effects?
Since this is about general health and wellness products for pain relief, specific side effects aren't listed but could range from none to potential mild discomfort depending on individual reactions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am willing to take a study drug without knowing if it's active or a placebo.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have severe heart disease, including heart failure or irregular heartbeats.
Select...
I have been diagnosed with liver or kidney disease.
Select...
I am not on medications that interact badly with the study drugs, like blood thinners, steroids over 5mg, certain infection treatments, mental health drugs, or MAOIs.
Select...
I cannot provide a valid US address and mobile number.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in pain interference
Secondary study objectives
Change in energy (fatigue)
Change in feelings of anxiety
Change in neuropathic pain
+7 more
Other study objectives
Change in focus (cognitive function)
Change in libido
Change in mood (emotional distress-depression)

Trial Design

9Treatment groups
Experimental Treatment
Placebo Group
Group I: Active Product 3.3Experimental Treatment1 Intervention
Relief Product Form 3 - active product 3
Group II: Active Product 3.2Experimental Treatment1 Intervention
Relief Product Form 3 - active product 2
Group III: Active Product 3.1Experimental Treatment1 Intervention
Relief Product Form 3 - active product 1
Group IV: Active Product 2.1Experimental Treatment1 Intervention
Relief Product Form 2 - active product 1
Group V: Active Product 1.2Experimental Treatment1 Intervention
Relief Product Form 1 - active product 2
Group VI: Active Product 1.1Experimental Treatment1 Intervention
Relief Product Form 1 - active product 1
Group VII: Placebo Control 2Placebo Group1 Intervention
Relief Product Form 2 - control
Group VIII: Placebo Control 1Placebo Group1 Intervention
Relief Product Form 1 - control
Group IX: Placebo Control 3Placebo Group1 Intervention
Relief Product Form 3 - control

Find a Location

Who is running the clinical trial?

Radicle ScienceLead Sponsor
21 Previous Clinical Trials
40,727 Total Patients Enrolled
3 Trials studying Pain
4,951 Patients Enrolled for Pain
Emily K. Pauli, PharmDPrincipal InvestigatorRadicle Science, Inc
17 Previous Clinical Trials
33,200 Total Patients Enrolled
2 Trials studying Pain
1,951 Patients Enrolled for Pain

Media Library

Pain Clinical Trial 2023: Placebo Control Form 1 Highlights & Side Effects. Trial Name: NCT05837923 — N/A
Placebo Control Form 1 (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05837923 — N/A
~1530 spots leftby Jul 2025